LSR 27-0452: Classifying 7-hydroxymitragynine, mitragynine pseudoindoxyl, MGM-15, and MGM-16 as schedule I controlled drugs

2027 session. Prime sponsor: Jason Janvrin. Status: LSR, not yet numbered.